Michigan State University will begin construction in August of 2017 on the $100 million Interdisciplinary Science and Technology Building in East Lansing. Supporting STEM programs in science, technology, engineering, and mathematics, the five-story, 170,000-sf facility will provide wet bench laboratories, offices, computational research space, and collaboration areas. Completion is expected in August of 2019.
Imperial College London began construction in early 2017 on the £70 million Michael Uren Biomedical Engineering Research Hub in London. Designed by Allies & Morrison, the collaborative 14-story building will provide flexible laboratories, an outpatient clinic, an auditorium, and interaction spaces. Located on the White City campus, the 215,000-sf translational research facility will be built to attain BREEAM sustainable design certification and will feature a highly efficient service model with interconnected utility plants on each floor.
The University of Calgary opened the CAD$174 million Canadian Natural Resources Limited Engineering Complex in November of 2016 in Alberta, Canada. Designed by Diamond Schmitt Architects, the expansion project comprises a 197,000-sf addition and 119,000 sf of renovated space for the Schulich School of Engineering. The collaborative facility features a programmable dynamic view glass façade and provides two new floors of research laboratories for the study of renewable energy resources and the development of clean energy technologies.
Los Angeles Biomedical Research Institute (LA Biomed) will begin construction in early 2017 on a four-story, 85,000-sf R&D facility on the campus of Harbor-UCLA Medical Center in Torrance, Calif. Consolidating operations currently dispersed in seven campus locations, the collaborative project will feature core labs with advanced technological instrumentation. A modular design will provide flexible wet and dry research spaces as well as conference and dining facilities.
Adelphi University celebrated the opening of the $76 million Nexus Building in December of 2016 in Garden City, N.Y. Designed by Ballinger, the collaborative 100,000-sf facility houses the College of Nursing and Public Health, the Center for Health Innovation, and a hub for core student services. The project also provides clinical simulation suites, research and informatics laboratories, and over 15 contemporary learning spaces.
The University of Melbourne is engaged in a 54,000-sf expansion of the Bio21 Molecular Science and Biotechnology Institute. Created in partnership with Australian biopharmaceutical firm CSL, the AUD$36.4 million project will house the CSL Global Hub for Research and Translational Medicine, which will feature advanced technologies for the creation of personalized medicine solutions. Completion is expected in mid-2017.
Johnson Controls is constructing the $150 million Applied Development and Engineering Center in Hopewell Township, Pa. Supporting the production of advanced air handlers and chillers, the two-building complex includes a 107,000-sf engineering facility and a 250,000-sf testing lab. The center was designed by IDC Architects, a subsidiary CH2M Hill, and is being built by a joint venture of McCarthy, Stewart & Tate Construction, and PJ Dick. Occupancy is expected in late 2017.
Texas Tech University is planning to build the $62 million Medical Science Building II in El Paso. Designed by Perkins+Will, the 227,000-sf facility will provide advanced research laboratories, classrooms, lecture halls, faculty and investigator offices, and support space. The general contractor for the project, which will include utility infrastructure and parking improvements, is Sundt Construction.
GlaxoSmithKline began construction in December of 2016 on a 100,000-sf SMART laboratory and office facility in Upper Providence, Pa. Skanska has been awarded the $45 million contract for demolition and renovation of four floors in an existing structure to implement GSK’s Smart Space concept, which features integrated technological innovations for research and productivity. Completion is expected in October of 2017.
Merck has selected Alexandria Real Estate Equities to develop a biopharmaceutical R&D facility in South San Francisco, Calif. Construction will begin in early 2017 on the nine-story, 294,000-rsf building, the entirety of which will be leased by Merck. Designed by DGA to accommodate up to 300 scientists engaged in collaborative, multidisciplinary research, the facility will provide laboratories, offices, a 300-seat auditorium, a café, and a fitness center.
The University of Houston opened the $51 million Multidisciplinary Research and Engineering Building in November of 2016. Designed by SHW Group, a subsidiary of Stantec, the four-story, 120,000-gsf project provides the Cullen College of Engineering with wet research labs, a visualization suite, an NMR spectrometry lab, offices, and conference rooms.
Great Ormond Street Hospital will begin construction in January of 2017 on the £42 million Zayed Centre for Research into Rare Disease in Children in London. Designed by Stanton Williams, the 140,000-sf translational research facility will provide collaborative biomedical labs and instrumentation suites to support the delivery of personalized gene and cell therapies and innovative medical devices.
Laurentian University is planning to build the CAD$30 million Clifford A. Fielding Research, Innovation and Engineering Building in Sudbury, Ontario. Housing the Bharti School of Engineering, the 47,000-sf project will include a technology-rich lecture hall, four capstone project labs, a prototyping and fabrication shop, a materials analysis lab, a hydraulics and fluid dynamics lab, and an environmental and soil mechanics lab.
ARIAD Pharmaceuticals’ new home in Cambridge, Mass., has 40,000 sf of high-tech biology and chemistry labs, along with four distinct space types to accommodate the work modes of its staff: focus, collaboration, learning, and social engagement. The new 130,000-rentable-square-foot headquarters, known by its address, 125 Binney Street, in the heart of the Kendall Square life science community, stands in marked contrast to the company’s existing facility, less than two miles away.
Pfizer will begin construction in mid-2017 on a $200 million research and development campus in Chesterfield, Mo. Supporting the creation of advanced vaccines, biotherapeutics, and pharmaceuticals, the project could include a 460,000-sf facility standing up to five stories high. The campus will be built by Clayco and its development subsidiary CRG, with Pfizer leasing the structures upon completion. Occupancy is expected in 2020.
